Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Surgical planning tool

This article was originally published in The Gray Sheet

Executive Summary

Belgium firm Materialise announces Sept. 17 plans for a randomized trial comparing standard X-ray-based surgical planning for wrist surgery and computer-assisted/computed tomography-based planning using the firm's 510(k)-cleared SurgiCase system. Materialise's technology or similar technology is marketed by several of the top orthopedics device firms as an add-on to their knee implant offerings (1"The Gray Sheet" Aug. 30, 2010)

You may also be interested in...

FDA Warning Letters Target Personalized Knee Surgery Systems

FDA's device center is warning two different orthopedic firms that the companies' personalized knee surgery instrumentation systems are being marketed without proper clearance or approval

Belgium Aims To Drive Biologic Competition Through Tendering

New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.

EU Bodies Agree On Ways To Future-Proof EMA Funding System

EU ministers say that implementing an appropriate fee structure that is more in line with actual costs will promote innovation in the pharmaceutical sector while ensuring “fair access” to safe and effective medicines for patients.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts